Decreased S100-beta protein in schizophrenia: preliminary evidence.
about
Evaluating genetic markers and neurobiochemical analytes for fluoxetine response using a panel of mouse inbred strainsSystematic review and meta-analysis of circulating S100B blood levels in schizophreniaTranslating potential biomarker candidates for schizophrenia and depression to animal models of psychiatric disorders.Levels of S100B are raised in female patients with schizophrenia.Replicated evidence of absence of association between serum S100B and (risk of) psychotic disorderSerum S100B Is Related to Illness Duration and Clinical Symptoms in Schizophrenia-A Meta-Regression Analysis.Higher Plasma S100B Concentrations in Schizophrenia Patients, and Dependently Associated with Inflammatory Markers.Cerebrospinal fluid: identification of diagnostic markers for schizophrenia.Negative Correlation between Serum S100B and Leptin Levels in Schizophrenic Patients During Treatment with Clozapine and Risperidone: Preliminary EvidenceBlood-brain barrier dysfunction in brain diseases: clinical experience.S100B and schizophrenia.A novel mechanism to explain protein abnormalities in schizophrenia based on the flavivirus resistance gene.S100 and cytokine expression in caries.Intracellular Ca2+ and Zn2+ levels regulate the alternative cell density-dependent secretion of S100B in human glioblastoma cells.Elevated serum S100B protein in first-episode drug-naive Chinese patients with schizophrenia.Serum Levels of S100b and NSE Proteins in Patients with Non-Transfusion-Dependent Thalassemia as Biomarkers of Brain Ischemia and Cerebral Vasculopathy.S100B serum levels and long-term improvement of negative symptoms in patients with schizophrenia.Regionally specific changes in levels of cortical S100beta in bipolar 1 disorder but not schizophrenia.Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology.Increased serum S100B protein in chronic schizophrenic patients in Korea.
P2860
Q24632901-F86D02B4-1DF8-44FE-B741-2E1E7D0741B8Q28542887-09461BB9-B0E1-41A9-AD72-6B38C2A12645Q34214660-E870C08E-7BD9-499E-878C-DD8BD471CA5EQ34738782-11E41B3E-6703-4FC3-B57A-D0F287384DA4Q35072837-4F59BA52-5200-4B40-96C0-A3692A310FA5Q36615271-D67BFA0E-E5D2-4387-8FD1-0F3ADBFE52A7Q36986134-E43C85C1-F253-4B5B-99AB-3E4A43F9B84BQ37118995-8289C89F-F785-4C96-A4B3-92162B661D05Q37178192-717FC76F-893F-46C5-9F58-D579A7A4C30BQ38058370-D3984475-143D-4B2A-9FC3-66D4068E066FQ38084359-D4BF0288-4C28-4041-8B78-5D91C2A0AA49Q40594390-F77AE4AF-6D5A-400D-9E31-5D254423BA29Q40936329-454FF040-D674-4458-99D3-F5429FE98567Q43636955-2661ED99-972D-4021-9D4B-58086FDFB99FQ46156029-573EE692-D069-4355-BB9C-70D3B6555CFDQ47175594-CEDCCC48-E353-460A-AAD7-B06AA37B5C65Q48008575-4A0377F6-914B-4083-B3D2-449F60E55826Q48651751-77C25B3A-F31F-4B95-B4EE-2E5A7EA2F5BFQ48819891-E0F048E7-915B-45A4-A5E8-B87EE9958EE4Q53558718-FA0C3AF5-2DEE-4D38-A6AC-A4A9A6A10117
P2860
Decreased S100-beta protein in schizophrenia: preliminary evidence.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Decreased S100-beta protein in schizophrenia: preliminary evidence.
@ast
Decreased S100-beta protein in schizophrenia: preliminary evidence.
@en
type
label
Decreased S100-beta protein in schizophrenia: preliminary evidence.
@ast
Decreased S100-beta protein in schizophrenia: preliminary evidence.
@en
prefLabel
Decreased S100-beta protein in schizophrenia: preliminary evidence.
@ast
Decreased S100-beta protein in schizophrenia: preliminary evidence.
@en
P2093
P1476
Decreased S100-beta protein in schizophrenia: preliminary evidence
@en
P2093
C A Gonçalves
L V Portela
W F Gattaz
P356
10.1016/S0920-9964(99)00146-2
P407
P577
2000-06-01T00:00:00Z